CVS Caremark spent $2M to lobby gov't in Q2

New York City CVS Caremark Corp. spent more than $2 million to lobby in the second quarter amid government efforts to pass healthcare reform.

CVS Caremark lobbied on reforms of insurance and Medicare and Medicaid, access to drugs, generic versions of pharmaceuticals and biotech drugs, and coverage of cancer drugs. It also lobbied on issues related to prescription-drug benefits, reimbursement for generic drugs and other bills related to drug rebates.

The company also spent about $2 million on lobbying in the first three months of the year.